These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33731514)

  • 1. Therapeutic Efficacy of Cryopreserved, Allogeneic Extracellular Vesicles for Treatment of Acute Myocardial Infarction.
    Chung JJ; Kim ST; Zaman S; Helmers MR; Arisi MF; Li EC; Tran Z; Chen CW; Altshuler P; Chen M; Burdick JA; Atluri P
    Int Heart J; 2021 Mar; 62(2):381-389. PubMed ID: 33731514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed delivery of endothelial progenitor cell-derived extracellular vesicles via shear thinning gel improves postinfarct hemodynamics.
    Chung JJ; Han J; Wang LL; Arisi MF; Zaman S; Gordon J; Li E; Kim ST; Tran Z; Chen CW; Gaffey AC; Burdick JA; Atluri P
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1825-1835.e2. PubMed ID: 31353103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.
    Chen CW; Wang LL; Zaman S; Gordon J; Arisi MF; Venkataraman CM; Chung JJ; Hung G; Gaffey AC; Spruce LA; Fazelinia H; Gorman RC; Seeholzer SH; Burdick JA; Atluri P
    Cardiovasc Res; 2018 Jun; 114(7):1029-1040. PubMed ID: 29566124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition.
    Huang G; Cheng Z; Hildebrand A; Wang C; Cimini M; Roy R; Lucchese AM; Benedict C; Mallaredy V; Magadum A; Joladarashi D; Thej C; Gonzalez C; Trungcao M; Garikipati VNS; Elrod JW; Koch WJ; Kishore R
    Theranostics; 2022; 12(9):4415-4430. PubMed ID: 35673580
    [No Abstract]   [Full Text] [Related]  

  • 5. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.
    Gaffey AC; Chen MH; Venkataraman CM; Trubelja A; Rodell CB; Dinh PV; Hung G; MacArthur JW; Soopan RV; Burdick JA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1268-76. PubMed ID: 26293548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.
    Firoozi S; Pahlavan S; Ghanian MH; Rabbani S; Barekat M; Nazari A; Pakzad M; Shekari F; Hassani SN; Moslem F; Lahrood FN; Soleimani M; Baharvand H
    Biochem Biophys Res Commun; 2020 Apr; 524(4):903-909. PubMed ID: 32057366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
    Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
    Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis.
    Wu Q; Wang J; Tan WLW; Jiang Y; Wang S; Li Q; Yu X; Tan J; Liu S; Zhang P; Tiang Z; Chen Z; Foo RS; Yang HT
    Cell Death Dis; 2020 May; 11(5):354. PubMed ID: 32393784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles derived from myocardial infarction plasma inhibit BMSCs apoptosis and enhance cardiac function via AKT signaling pathway.
    Jin P; Ding L; Wang L; Jiang S; Weng J; Gao Y; Fan J; Sun LZ
    Int Immunopharmacol; 2021 Jul; 96():107730. PubMed ID: 34020395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M1 Bone Marrow-Derived Macrophage-Derived Extracellular Vesicles Inhibit Angiogenesis and Myocardial Regeneration Following Myocardial Infarction via the MALAT1/MicroRNA-25-3p/CDC42 Axis.
    Chen B; Luo L; Wei X; Gong D; Li Z; Li S; Tang W; Jin L
    Oxid Med Cell Longev; 2021; 2021():9959746. PubMed ID: 34745428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface engineering enhances the therapeutic potential of systemically delivered extracellular vesicles following acute myocardial infarction.
    Mentkowski KI; Tarvirdizadeh T; Manzanero CA; Eagler LA; Lang JK
    FASEB J; 2024 Sep; 38(18):e70070. PubMed ID: 39301939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction.
    Song Y; Zhang C; Zhang J; Jiao Z; Dong N; Wang G; Wang Z; Wang L
    Theranostics; 2019; 9(8):2346-2360. PubMed ID: 31149048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-Cardiac Release of Extracellular Vesicles Shapes Inflammation Following Myocardial Infarction.
    Loyer X; Zlatanova I; Devue C; Yin M; Howangyin KY; Klaihmon P; Guerin CL; Kheloufi M; Vilar J; Zannis K; Fleischmann BK; Hwang DW; Park J; Lee H; Menasché P; Silvestre JS; Boulanger CM
    Circ Res; 2018 Jun; 123(1):100-106. PubMed ID: 29592957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.
    Hocine HR; Brunel S; Chen Q; Giustiniani J; San Roman MJ; Ferrat YJ; Palacios I; de la Rosa O; Lombardo E; Bensussan A; Charron D; Jabrane-Ferrat N; Al-Daccak R
    Stem Cells Transl Med; 2019 Sep; 8(9):911-924. PubMed ID: 30924311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of βARKct engineered cellular extracellular vesicles and model specific cardioprotection.
    Kwon JS; Schumacher SM; Gao E; Chuprun JK; Ibetti J; Roy R; Khan M; Kishore R; Koch WJ
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1276-H1289. PubMed ID: 33513081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of progenitor cells with injectable shear-thinning hydrogel maintains geometry and normalizes strain to stabilize cardiac function after ischemia.
    Gaffey AC; Chen MH; Trubelja A; Venkataraman CM; Chen CW; Chung JJ; Schultz S; Sehgal CM; Burdick JA; Atluri P
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1479-1490. PubMed ID: 30579534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injury minimization after myocardial infarction: focus on extracellular vesicles.
    Barile L; Marbán E
    Eur Heart J; 2024 May; 45(18):1602-1609. PubMed ID: 38366191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death.
    Khandagale A; Lindahl B; Lind SB; Shevchenko G; Siegbahn A; Christersson C
    Curr Res Transl Med; 2022 May; 70(2):103323. PubMed ID: 34979484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment.
    Yue Y; Wang C; Benedict C; Huang G; Truongcao M; Roy R; Cimini M; Garikipati VNS; Cheng Z; Koch WJ; Kishore R
    Circ Res; 2020 Jan; 126(3):315-329. PubMed ID: 31815595
    [No Abstract]   [Full Text] [Related]  

  • 20. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors.
    El Harane N; Kervadec A; Bellamy V; Pidial L; Neametalla HJ; Perier MC; Lima Correa B; Thiébault L; Cagnard N; Duché A; Brunaud C; Lemitre M; Gauthier J; Bourdillon AT; Renault MP; Hovhannisyan Y; Paiva S; Colas AR; Agbulut O; Hagège A; Silvestre JS; Menasché P; Renault NKE
    Eur Heart J; 2018 May; 39(20):1835-1847. PubMed ID: 29420830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.